lde225 and Carcinoma--Basosquamous

lde225 has been researched along with Carcinoma--Basosquamous* in 3 studies

3 other study(ies) available for lde225 and Carcinoma--Basosquamous

Article	Year
Neoadjuvant treatment of basosquamous carcinomas with Sonidegib: An innovative approach. Experimental dermatology, 2023, Volume: 32, Issue:11 Topics: Biphenyl Compounds; Carcinoma, Basal Cell; Carcinoma, Basosquamous; Humans; Neoadjuvant Therapy; Skin Neoplasms	2023
Impressive response to four cemiplimab cycles of a sonidegib-resistant giant basosquamous carcinoma of the midface. Journal of the European Academy of Dermatology and Venereology : JEADV, 2022, Volume: 36, Issue:6 Topics: Antibodies, Monoclonal, Humanized; Biphenyl Compounds; Carcinoma, Basosquamous; Humans; Pyridines; Skin Neoplasms	2022
Locally advanced basosquamous carcinoma: Our experience with sonidegib. Dermatologic therapy, 2022, Volume: 35, Issue:6 Topics: Antineoplastic Agents; Biphenyl Compounds; Carcinoma, Basal Cell; Carcinoma, Basosquamous; Humans; Pyridines; Skin Neoplasms	2022